NEW YORK (GenomeWeb News) – Korean oligo manufacturer Bioneer has opened a US subsidiary in Alameda, Calif. today, the Korean biotech company said today.
Bioneer selected the site for its manufacturing facility and distribution center to be near San Francisco’s biotech hub and “for environmental conditions ideally suited” to synthetic oligonucleotide production.
The 22,000-square-foot facility will have the capacity to manufacture 6,000 oligos per day. The fir said capacity will rise with increased demand.
Since its IPO in December 2005, Bioneer has expanded into North America and Europe. The company delivers oligos in combination with its AccuPower technology for PCR.